Scientific Publications

Citizens of Science

In our quest to invent life-transforming medicines for people with serious diseases, we encourage our colleagues to publish their research in leading scientific journals.

The links on this page are not affiliated with Regeneron Pharmaceuticals, Inc. Links to sites outside of Regeneron are provided as a resource to the viewer. Regeneron accepts no responsibility for the content of linked sites.

Featured Publications
  • Early-Stage Research
  • Clinical Research
Genetics
Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity

Published in Science. 2021 Jul 2;373(6550):eabf8683. doi: 10.1126/science.abf8683.

Computationally efficient whole-genome regression for quantitative and binary traits

Published in Nat Genet. 2021 May 20. doi: 10.1038/s41588-021-00870-7. Online ahead of print.

Immunology & Inflammation
A BCMAxCD3 bispecific T cell-engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells

Published in Blood Advances (2021) 5:5 (1291-1304). Date of Publication: 9 Mar 2021

Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses

Published in Sci Immunol. 2021 Apr 9;6(58):eabg0117. doi: 10.1126/sciimmunol.abg0117

Enhanced IL-36R signaling promotes barrier impairment and inflammation in skin and intestine

Published in Sci Immunol 10.1126/sciimmunol.aax1686

Infectious Diseases
SARS-CoV-2 spike therapeutic antibodies in the age of variants

Published in J Exp Med. 2021 May 3;218(5):e20210198. doi: 10.1084/jem.20210198.

Oncology
Preclinical PET imaging with the novel human antibody 89 Zr-DFO-REGN3504 sensitively detects PD-L1 expression in tumors and normal tissues

Published in Journal for ImmunoTherapy of Cancer (2021) 9:1 Article Number: e002025. Date of Publication: 22 Jan 2021

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Published in Lancet. 2021 Feb 13;397(10274):592-604. doi: 10.1016/S0140-6736(21)00228-2.

Technology
A framework for highly multiplexed dextramer mapping and prediction of T cell receptor sequences to antigen specificity

Published in Sci Adv. 2021 May 14;7(20):eabf5835. doi: 10.1126/sciadv.abf5835. Print 2021 May.

Tissue-specific activation of gene expression by the Synergistic Activation Mediator (SAM) CRISPRa system in mice

Published in Nat Commun. 2021 May 13;12(1):2770. doi: 10.1038/s41467-021-22932-4.

Immunology & Inflammation
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease

Published in Nat Immunol. 2021 Feb;22(2):128-139. doi: 10.1038/s41590-020-00830-z. Epub 2021 Jan 4.

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

Published in Lancet Oncol. 2021 May 14:S1470-2045(21)00126-1. doi: 10.1016/S1470-2045(21)00126-1. Online ahead of print.

Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUEST

Published in Allergy. 2021 Apr 27. doi: 10.1111/all.14872. Online ahead of print.

Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-Induced Allergic Rhinitis: A Randomized, Double-blind, Placebo Controlled Trial

Published in Am J Respir Crit Care Med. 2021 Mar 2. doi: 10.1164/rccm.202011-4107OC. Online ahead of print.

Infectious Diseases
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

Published in N Engl J Med. 2020 Dec 17. doi: 10.1056/NEJMoa2035002

The monoclonal antibody combination REGEN-COV protects against SARS- CoV-2 mutational escape in preclinical and human studies

Published in Cell (2021), doi: https://doi.org/10.1016/ j.cell.2021.06.002.

Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)

Published in The Journal of infectious diseases (2021). Date of Publication: 28 Jan 2021

Back to top